In ccRCC, the expression of FDX1 was significantly lower than that in normal tissues, and the low expression of FDX1 was in turn associated with progression, poor prognosis, and dysregulated immune cell infiltration in ccRCC [92]. The gene discussed is FDX1; the disease is nonpapillary renal cell carcinoma.